SCHEMBL30607447

CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CS)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O)[C@@H](C)CC

nearest known ligand 0.64

Predicted protein targets (top 5)

	gene	UniProt	supporting neighbours	confidence
▸	CALCR	P30988	4/20	0.58

▸	TFPI	P10646	1/20	0.56

▸	VIPR1	P32241	1/20	0.56

▸	GLP1R	P43220	2/20	0.56

▸	PTH1R	Q03431	1/20	0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30576978	0.94	VIPR1 (0.58)	CALCRTFPIVIPR1GLP1RPTH1R
SCHEMBL30712875	0.91	TFPI (0.62)	TFPI
SCHEMBL30495734	0.90	VIPR1 (0.62)	TFPIVIPR1GLP1RPTH1R
SCHEMBL30906541	0.90	TFPI (0.61)	TFPIVIPR1GLP1RPTH1R
SCHEMBL30432769	0.90	BACE1 (0.61)	CALCRVIPR1GLP1R
SCHEMBL30446700	0.90	TFPI (0.63)	CALCRTFPIVIPR1GLP1RPTH1R
SCHEMBL30447212	0.90	TFPI (0.64)	TFPIVIPR1GLP1RPTH1R
SCHEMBL30712876	0.90	OPRM1 (0.54)	TFPIVIPR1GLP1R
SCHEMBL30688341	0.89	GLP1R (0.58)	CALCRTFPIVIPR1GLP1R
SCHEMBL29394956	0.89	BACE1 (0.58)	VIPR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-12383505-B2	Nanoparticle for the remodeling of cancer-associated fibroblasts	UNIVERSITY OF SOUTH CAROLINA (US)	2025-08-12	—	—	US	disclosed
US-20230310331-A1	NANOPARTICLE FOR THE REMODELING OF CANCER-ASSOCIATED FIBROBLASTS	UNIVERSITY OF SOUTH CAROLINA (US)	2023-10-05	—	—	US	disclosed